Chikungunya virus vaccine (Merck Sharp & Dohme)
N/A
Report date: 2022/01/25 17:35:06
Base Information
Drug NameChikungunya virus vaccine (Merck Sharp & Dohme)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A
Develop Information
Active CompaniesThemis Bioscience Gmbh
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A